Total investments received (USD): 13.83m
Round value (USD): N/A
Round investors:
b.value AG
ACT Venture Partners
Company: Cellbricks Therapeutics
Industry:
Health services
Manufacturing


Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom